메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
(Ulsan National Institute of Science and Technology) (Ulsan National Institute of Science and Technology) (Ulsan National Institute of Science and Technology)
저널정보
대한의용생체공학회 Biomedical Engineering Letters (BMEL) Biomedical Engineering Letters (BMEL) Vol.11 No.3
오류 신고하기

피인용 0

검색

    초록·키워드

    The CRISPR-based genome editing technology has opened extremely useful strategies in biological research and clinicaltherapeutics, thus attracting great attention with tremendous progress in the past decade. Despite its robust potential inpersonalized and precision medicine, the CRISPR-based gene editing has been limited by ineffi cient in vivo delivery to thetarget cells and by safety concerns of viral vectors for clinical setting. In this review, recent advances in tailored nanoparticlesas a means of non-viral delivery vector for CRISPR/Cas systems are thoroughly discussed. Unique characteristics ofthe nanoparticles including controllable size, surface tunability, and low immune response lead considerable potential ofCRISPR-based gene editing as a translational medicine. We will present an overall view on essential elements in CRISPR/Cas systems and the nanoparticle-based delivery carriers including advantages and challenges. Perspectives to advance thecurrent limitations are also discussed toward bench-to-bedside translation in engineering aspects.

    최근 본 자료 전체보기